Vazula Bekkers

6. Needle-free electronically-controlled jet injector treatment with bleomycin and lidocaine is effective and welltolerated in patients with recalcitrant keloids. 170 10. Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatol Surg. Jan 2017;43 Suppl 1:S3-S18. doi:10.1097/DSS.0000000000000819 11. Morelli Coppola M, Salzillo R, Segreto F, Persichetti P. Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018;11:387-396. doi:10.2147/CCID.S133672 ccid-11-387 [pii] 12. Sproat JE, Dalcin A, Weitauer N, Roberts RS. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment. Plast Reconstr Surg. Dec 1992;90(6):98892. 13. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg. Feb 2010;125(2):557-568. doi:00006534-201002000-00019 [pii]10.1097/PRS.0b013e3181c82dd5 14. Ud-Din S, Bowring A, Derbyshire B, Morris J, Bayat A. Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease. Arch Dermatol Res. Jul 2013;305(5):423-32. doi:10.1007/s00403-013-1328-7 15. Logomasini MA, Stout RR, Marcinkoski R. Jet injection devices for the needle-free administration of compounds, vaccines, and other agents. Int J Pharm Compd. Jul-Aug 2013;17(4):270-80. 16. Bik L EI, Wolkerstorfer A, Prens E, van Doorn MBA. Needle-free electronicallycontrolled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey [Submitted]. 2022; 17. Bik L, Sangers T, Greveling K, Prens E, Haedersdal M, van Doorn M. Efficacy and tolerability of intralesional bleomycin in dermatology: A systematic review. J Am Acad Dermatol. Sep 2020;83(3):888-903. doi:S0190-9622(20)30226-7 [pii]10.1016/j.jaad.2020.02.018 18. Viera MH, Caperton CV, Berman B. Advances in the treatment of keloids. J Drugs Dermatol. May 2011;10(5):468-80.

RkJQdWJsaXNoZXIy MTk4NDMw